ALNY   $244.91  -0.77% Market Closed After Close 244.4 -0.21%

Alnylam Pharmaceuticals Inc

EMA (20): 2024-11-12 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-11-12 the price crossed down the moving average line and trying to form a short-term downside trend.

EMA (100): 2024-11-15 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

Trend Type flat and up
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -8.95%
EMA (20) date of signal Nov. 12, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -8.95%
EMA (50) date of signal Nov. 12, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield 3.97%
EMA (100) date of signal Nov. 15, 2024, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -0.77%
RSI (14) date of signal Nov. 21, 2024, 3 a.m.
MACD Signals bearish recovery
MACD Yield 0.0
MACD date of signal Nov. 22, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 0.0
Stochastic date of signal Nov. 22, 2024, 3 a.m.
Updated Nov. 23, 2024, 11 p.m.